This company has shut down. CODA Biotherapeutics is no longer operating — its last tracked round was a Venture - Series Unknown in 2021.
Explore the Startup GraveyardCODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
CODA Biotherapeutics has raised $28.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2021.
CODA Biotherapeutics's investors include Novartis, Versant Ventures, Silicon Valley Bank, National Institutes of Health, MPM Capital.
CODA Biotherapeutics is headquartered in South San Francisco, United States.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
CODA Biotherapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CODA Biotherapeutics — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/coda-biotherapeutics. Accessed September 30, 2026.
VCBacked. (2021). CODA Biotherapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/coda-biotherapeutics
{{cite web |title=CODA Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/coda-biotherapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated